Focused Light Scattering for Nanoparticle Characterization

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for characterizing biological particles are limited in detecting sizes smaller than microparticles and lack accuracy in quantifying and monitoring nanoparticles, which are crucial for diagnosing diseases and evaluating therapeutic agents.

Innovation Solution

Focused light scattering techniques are used to detect and characterize biological particles by passing a sample through a focused beam of light, allowing for the measurement of particle sizes ranging from 0.1 to 100 μm, and employing mathematical algorithms to determine particle sizes, distributions, and shapes, enabling the identification of specific cells, bacteria, fungi, or viruses, and monitoring complex formations with therapeutic agents.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional light scattering methods are used, then microparticles can be detected, but nanoparticles smaller than microparticles cannot be accurately detected

Engineering Contradiction:
Improveparticle size detection capabilityVSAvoiddetection range
Core Design Contradiction:
Measurement precisionVSAdaptability or versatility

Solution Approach 1:

The patent changes the optical parameters by using focused light scattering with specific numerical apertures and detection angles. The system uses a focused beam with numerical aperture 0.1-0.5 and detects scattered light at angles 10-170 degrees, enabling accurate detection of nanoparticles down to 10nm while maintaining microparticle detection capability.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent adds angular dimension to light scattering detection by measuring scattered light intensity at multiple angles (10-170 degrees) rather than a single angle. This multi-angular detection approach provides additional information that enables accurate size determination across the full range from 10nm to 100μm.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Measurement precision

If flow cytometry is used for particle characterization, then accurate detection is achieved, but high cost and complexity are incurred

Engineering Contradiction:
Improveparticle characterization accuracyVSAvoidsystem complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent replaces expensive, complex flow cytometry systems with a simpler, more affordable light scattering apparatus. The system uses conventional light sources, simple optics, and basic detectors that can be implemented at lower cost while achieving comparable or superior nanoparticle detection capability.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The patent extracts and utilizes only the essential light scattering measurement capability, removing the complex fluorescent labeling, multiple lasers, and sophisticated sorting mechanisms of flow cytometry. This simplified approach focuses on particle size and shape characterization through elastic light scattering alone.

Inventive Principle:
Principle #2Taking out (Extraction)

3Reliability

If fluorescent antibodies are used for particle detection, then specific binding can be detected, but expensive reagents and complex procedures are required

Engineering Contradiction:
Improvebinding detection accuracyVSAvoidassay simplicity
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The patent replaces the biochemical fluorescent antibody binding system with a physical light scattering measurement system. Instead of relying on specific antigen-antibody interactions and fluorescent labels, the system detects particles through their intrinsic light scattering properties, which depend on size, shape, and refractive index.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent utilizes the particles' own physical properties (size, shape, refractive index) to generate the detection signal through elastic light scattering. No external labels, reagents, or complex preparation steps are needed—the particles themselves provide the measurement signal through their interaction with light.

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method provides high-throughput bioassays and personalized medicine approaches by accurately detecting and characterizing smaller biological particles, determining therapeutic agent binding, and assessing disease states without the need for fluorescent antibodies or expensive flow cytometry, improving resolution and efficiency in particle analysis.

Implementation Method 1

Focused light scattering techniques are used to detect and characterize biological particles by passing a sample through a focused beam of light

Methodology Applied
Scientific EffectLight scattering: Scattering

Data Source

PatentUS10359349B2Use of focused light scattering techniques in biological applications
Publication Date: 2019.07.23 INVITROX INC
  • US10359349B2 patent drawing
  • US10359349B2 patent drawing
  • US10359349B2 patent drawing

AI summary

Methods for using focused light scattering techniques for the optical sensing of biological particles suspended in a liquid medium are disclosed. The optical sensing enables one to characterize particles size and/or distribution in a given sample. This, in turn, allows one to identify the biological particles, determine their relative particle density, detect particle shedding, and identify particle aggregation. The methods are also useful in screening and optimizing drug candidates, evaluating the efficacy and dosage levels of such drugs, and in personalized medicine applications.